Ark Bio

About:

Ark Bio is a medical technology company

Website: http://ark.bio/

Top Investors: Gaorong Capital, Venturecraft Group

Description:

Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops non-invasive and cost-effective blood tests to detect early stage cancers before clinical symptoms appear. The company collaborates extensively with top medical research institutions globally and is spearheading Asia’s largest miRNA clinical studies targeting more than 50,000 participants. Ark is headquartered in Singapore, with R&D, manufacturing and clinical diagnostic operations in China and USA.

Total Funding Amount:

$40M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2018-01-01

Contact Email:

info(AT)ark.bio

Founders:

Isaac Ho, Zhou Lihan, Zou Ruiyang

Number of Employees:

11-50

Last Funding Date:

2018-11-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai